MANILA – Japan and the Philippines exchanged diplomatic notes Wednesday for the ¥50 billion loan assistance from the Japanese government to support the Philippines’ emergency response to the new coronavirus as well as related social protection, relief, and economic recovery stimulus measures.
Read More...
TOKYO – Gilead Sciences Inc., the U.S. pharmaceutical firm that developed remdesivir, priced the antiviral drug at $2,340 dollars, equivalent to more than ¥250,000, per COVID-19 patient for wealthy countries like Japan.
Read More...
For its 70th anniversary celebration, the country’s leading and largest broadcast firm GMA Network, Inc. wholeheartedly offers its own high-quality and affordable Digital Terrestrial Television (DTT) receiver "GMA Affordabox."
Read More...
The Japan International Cooperation Agency and the Department of Finance signed a combined total of 154 billion yen Official Development Assistance for infrastructure projects in Cebu and Davao emphasizing JICA's support to the Philippine economy affected by COVID-19.
Read More...
MANILA/TOKYO – Clinical trials in the Philippines will begin soon for the Japanese antiviral drug Avigan, also known as favipiravir, to determine if it is effective in treating the new coronavirus (COVID-19).
Read More...
